The effect of smoking on QuantiFERON results in diagnosis of latent tuberculosis infection

Özlem Salman Sever (Ankara, Turkey), Özlem Salman Sever, Balam Er Dedekarginoglu, Mahal Alekberov, Fusun Oner Eyupoglu

Source: International Congress 2016 – Latent tuberculosis infection
Session: Latent tuberculosis infection
Session type: Oral Presentation
Number: 3042
Disease area: Respiratory infections

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Özlem Salman Sever (Ankara, Turkey), Özlem Salman Sever, Balam Er Dedekarginoglu, Mahal Alekberov, Fusun Oner Eyupoglu. The effect of smoking on QuantiFERON results in diagnosis of latent tuberculosis infection. Eur Respir J 2016; 48: Suppl. 60, 3042

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment for latent tuberculosis infection in migrants carries a low risk of hepatotoxicity
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014


Tuberculin skin testing to the IGRA positive contacts of infectious tuberculosis cases for the treatment of latent tuberculosis infection
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015


Correlation between tuberculin-skin-test and interferon-gamma-release-assays with risks factors for tuberculosis infection
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013


New-immigrant screening for latent tuberculosis infection: Reasons for non-treatment
Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis
Year: 2013



A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016


Diagnosis of latent tuberculosis infection in children with the useof different immunological methods
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016


The value of immunological methods in the diagnosis of tuberculosis in patients with HIV
Source: International Congress 2015 – Screening strategies in TB
Year: 2015


Tuberculin skin test or interferon gamma release assay - How to detect latent tuberculosis infection in sarcoidosis patients?
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015

QuantiFERON-TB Gold in-tube test for diagnosis of latent tuberculosis (TB) infection among immunocompromised adults
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013



Latent TB infection in health care TB workers
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014


Clinical evaluation of several biomarkers including IFN-γ for the diagnosis of tuberculosis infection
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016

Quantiferon-TB Gold in tube assay for detecting latent TB infection in immigrants and TB contacts
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013

Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015

Are there any similarities between the skin and the blood tests with CFP10-ESAT6 in tuberculosis patients?
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013

Contribution of the T-SPOT.TB assay for differentiating active versus latent tuberculosis infection (LTBI)
Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection
Year: 2006


Outcomes of early interferon-gamma release assay (IGRA) testing in recent contacts of smear positive pulmonary tuberculosis (TB)
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013


Clinical evaluation of IP-10 and MIG including IGRAs (QFT and T-SPOT) for the diagnosis of tuberculosis infection
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014

Risk factors for latent tuberculosis infection in close contacts of active tuberculosis patients in South Korea
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013

QuantiFERON-TB GIT (QFT-GIT) vs TST in diagnosis of latent tuberculosis (TB) infection (LTBI) in household TB contacts in poland
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009


Comparative results of skin testing using tuberculosis allergen recombinant (CFP-10-ESAT-6) and QuantiFERON – GIT in children and adolescents with TB infection
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014